🟢 Beam Therapeutics is trading 5% up today as markets rebound after Fed decision

Beam Therapeutics is trading 5.06% up at $24.27 as U.S. markets rally following easing policy uncertainty after the Federal Reserve’s September 16 rate decision.

• The Nasdaq Composite is up 1.24% and the S&P 500 is up 0.96% on September 17, 2026.
• No new company-specific announcement dated September 17 was identified.
• The latest notable catalyst remains September 8’s BEAM-302 clinical update, followed by pressure rather than a clear same-day explanation for the current gain.